Fanlu Li

Papers

Total Citations

H-Index

About

Fanlu Li is a clinical researcher whose work centers on prognostic biomarkers in pancreatic cancer, with a particular focus on improving surgical outcomes for patients with pancreatic ductal adenocarcinoma (PDAC). Li’s most impactful contribution to date is the landmark 2021 study "Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection," which has garnered 8 citations. This research addresses a critical gap in the literature by demonstrating that elevated preoperative D-dimer levels serve as an independent predictor of poor survival in PDAC patients after radical surgery—a finding that challenges prior controversies and offers a readily available, low-cost tool for risk stratification. By establishing D-dimer as a clinically meaningful biomarker, Li’s work has direct implications for preoperative counseling and personalized treatment planning in pancreatic oncology. This study stands as a testament to Li’s ability to translate routine laboratory parameters into actionable prognostic insights, marking an important step forward in the fight against one of the most lethal malignancies.